Filing Flows › Elite Pharmaceuticals (ELTP) › Capital expenditures
Elite Pharmaceuticals (ELTP) capital expenditures by quarter
Elite Pharmaceuticals' capital expenditures were $809K in Q1 FY27 (first quarter fiscal 2027), +103% from Q4 FY26. Over the last 5 quarters it ranged from $103K (Q2 FY26) to $809K (Q1 FY27).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $809K | +103% | +271% |
| Q4 FY26 | $398K | +285% | -47% |
| Q2 FY26 | $103K | -53% | — |
| Q1 FY26 | $218K | -71% | — |
| Q4 FY25 | $754K | — | — |
Q1 FY27 at a glance
Elite Pharmaceuticals, Q1 FY27: revenue $32.4M (-20% year over year), operating margin 23.3%, net earnings $5.9M, operating cash flow $10.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Elite Pharmaceuticals' capital expenditures?
Elite Pharmaceuticals' capital expenditures were $809K in Q1 FY27 (first quarter fiscal 2027), +103% from Q4 FY26.
How has Elite Pharmaceuticals' capital expenditures changed?
Over the last 5 quarters it ranged from $103K (Q2 FY26) to $809K (Q1 FY27).